Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

被引:72
|
作者
Cartledge, JJ
Eardley, I
Morrison, JFB
机构
[1] St Jamess Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates
关键词
erectile dysfunction; diabetes mellitus; advanced glycation end-products (AGEs); aminoguanidine;
D O I
10.1046/j.1464-410x.2001.00067.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if advanced glycation products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats. Materials and methods Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and in an organ bath to measure isometric After 90 min of equilibration at optimal resting tension and contraction with 1 mu mol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 mu mol/L) and atropine (1 mu mol/L) was determined for each group. Results There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA(1c)) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA(1c). The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar. Conclusion AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [41] Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes
    Cartledge, JJ
    Eardley, I
    Morrison, JFB
    BJU INTERNATIONAL, 2001, 87 (04) : 394 - 401
  • [42] IS THERE A RELATIONSHIP BETWEEN ADVANCED GLYCATION END-PRODUCTS AND SOLUBLE RECEPTORS OF ADVANCED GLYCATION END-PRODUCTS WITH THE ETIOLOGY AND SEVERITY OF CONGESTIVE HEART FAILURE?
    Parsa, A. F. Zand
    Nejati, S.
    Esteghamati, A.
    CARDIOLOGY, 2015, 131 : 294 - 294
  • [43] Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)
    Yamagishi, Sho-ichi
    Matsui, Takanori
    CURRENT DRUG TARGETS, 2010, 11 (07) : 875 - 881
  • [44] Advanced glycation end-products and their receptors: Exercise effects
    Kotani, Kazuhiko
    Gugliucci, Alejandro
    OBESITY REVIEWS, 2020, 21 (06)
  • [45] Accumulation of advanced glycation end-products in human dentine
    Miura, Jiro
    Nishikawa, Kantaro
    Kubo, Mizuho
    Fukushima, Shuichiro
    Hashimoto, Mamoru
    Takeshige, Fumio
    Araki, Tsutomu
    ARCHIVES OF ORAL BIOLOGY, 2014, 59 (02) : 119 - 124
  • [46] Advanced glycation end-products (AGEs): new toxins?
    Boulanger, E
    Dequiedt, P
    Wautier, JL
    NEPHROLOGIE, 2002, 23 (07): : 351 - 359
  • [47] The association of advanced glycation end-products with glutathione status
    Sahin, Emel
    Gocmen, Ayse Yesim
    Kocak, Hueseyin
    Tuncer, Murat
    Gumuslu, Saadet
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 369 - 374
  • [48] Physiological and pathophysiological importance of advanced glycation end-products
    Simm, A.
    Ruhs, S.
    Nass, N.
    Bartling, B.
    Broemme, H. J.
    Leuner, B.
    Somoza, V.
    Friess, U.
    Silber, R. E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S11 - S11
  • [49] Clinical/Translational Aspects of Advanced Glycation End-Products
    Zeng, Chang
    Li, Yuanyuan
    Ma, Jingzhi
    Niu, Lina
    Tay, Franklin R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (12): : 959 - 973
  • [50] The health risks of dietary advanced glycation end-products
    Pischetsrieder, Monika
    Buetler, Timo
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (09) : 1071 - 1073